ParkerVision 2025 Annual Report: Essential Insights for Investors

Executive Overview

ParkerVision, Inc. (“ParkerVision” or “the Company”) released its Form 10-K for the fiscal year ended December 31, 2025. The report contains several critical updates for shareholders, including ongoing financial challenges, potential share dilution, legal and patent proceedings, and risks that could materially affect the Company’s value and future operations.

Key Financial Highlights and Concerns

• Substantial Doubt About Going Concern: The Company’s independent registered public accounting firm included a statement noting substantial doubt about ParkerVision’s ability to continue as a going concern. This is due to continued significant losses, negative cash flows, and an accumulated deficit of approximately \$455.6 million as of December 31, 2025.
• Ongoing Losses: Net losses for 2025 and 2024 were approximately \$7.4 million and \$14.5 million, respectively.
• Insufficient Capital Resources: As of December 31, 2025, ParkerVision held \$4.4 million in cash and cash equivalents, which is not sufficient to fund working capital needs for the next twelve months. The Company’s business plan will require additional expenditures for patent protection, enforcement, and general operations.
• Need for Additional Capital: The Company acknowledges the need to raise substantial additional capital to fund operations. Failure to do so could result in the inability to implement business plans or meet current obligations, which would be highly detrimental to investor interests.
• Recent Financing Activities:
  • In November 2025, ParkerVision completed two registered direct offerings with accredited investors for net proceeds of about \$4.4 million.
  • In March 2026, the Company issued 3.3 million shares to satisfy approximately \$0.7 million in convertible debt and related interest maturing in March 2026.
• Outstanding Convertible Debt: As of year-end 2025, ParkerVision had \$3.1 million in principal under convertible notes. If the Company defaults, the notes could become payable immediately at an increased interest rate (12% per annum), and the Company may not have sufficient funds to repay them.
• Potential Dilution: The Company has outstanding options, restricted share units, and warrants for up to 29.3 million shares. Additionally, up to 24.7 million shares could be issued upon conversion of convertible notes. Most of these shares are already registered for resale, which increases the risk of share dilution and downward pressure on the stock price.

Legal and Patent Proceedings

• Patent Litigation: ParkerVision continues to invest significant resources in patent enforcement actions. Notably, in January 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) granted the Company’s motion for an expected appeal in the patent infringement case against Qualcomm, with oral arguments anticipated in the next available session.
• Arbitration with Former Litigation Firm: The Company is in arbitration with a former litigation firm over disputed amounts due upon contract termination.
• Risks of Uncertain Litigation Outcomes: The outcome of ongoing or future litigation is uncertain and could have a significant impact on financials and future revenue.

Risks and Operational Challenges

• Dependence on Patent Licensing: The core business model relies on licensing and enforcing wireless technology patents. Ongoing patent enforcement is critical, and failure could hinder revenues and threaten viability.
• Industry Headwinds: The Company’s industry is characterized by rapid technological change. Due to limited financial resources, ParkerVision has ceased research and development activities, risking loss of future market opportunities.
• Leadership and Talent Risk: The Company is highly dependent on CEO Jeffrey Parker. Loss of his services could further impede the business plan. A \$1.5 million key-man life insurance policy is in place.
• Regulatory and Legislative Risks: Changes in patent law or regulations could adversely affect the Company’s ability to protect and monetize its intellectual property.
• Cybersecurity: ParkerVision reports no material losses from cyber-attacks so far but acknowledges the risk of significant operational or reputational harm from future incidents.

Common Stock and Shareholder Information

• Stock Performance and Trading: The common stock trades on the OTCQB under the symbol “PRKR.” The OTCQB is a less liquid market than national exchanges, which can make it difficult for shareholders to sell shares at desired prices.
• Share Price Volatility: Between January 2025 and March 2026, the share price has ranged from \$0.09 to \$1.18, indicating substantial volatility.
• Penny Stock Classification: In prior periods, the stock has been classified as a “penny stock,” which imposes additional compliance and disclosure requirements on broker-dealers and may affect liquidity and investor interest.
• No Dividends: ParkerVision does not pay dividends and intends to retain earnings to fund operations. Future dividends, if any, will be at the discretion of the Board.
• Shareholder Base: As of March 19, 2026, there were approximately 64 holders of record and an estimated 6,600 beneficial holders of common stock. Outstanding shares totaled 147,535,024.
• Anti-Takeover Provisions: Provisions in the Company’s certificate of incorporation and by-laws could make it harder for third parties to acquire control, including a staggered board and the ability to issue preferred stock without shareholder approval.

Other Noteworthy Information

• Remote Work: Since November 2020, all employees have worked remotely, a structure which the Company deems suitable for current operations.
• No Recent Unregistered Securities Sales: No unregistered securities sales or equity purchases by the issuer or affiliates occurred in Q4 2025.
• SEC Filings and Investor Resources: The Company files annual, quarterly, and other reports with the SEC and makes them available on its website.

Potential Price-Sensitive Issues for Shareholders

• Going Concern Risk: The auditor’s warning on the ability to continue as a going concern is material and may affect investor confidence and share price.
• Ongoing and Potential Dilution: Large numbers of potentially dilutive securities could put downward pressure on the share price.
• Pending Litigation Outcomes: The appeals process in the Qualcomm case and other patent litigation is a significant catalyst that could affect the Company’s value, depending on outcomes.
• Liquidity Constraints: The need to secure additional funding in the near term is critical. Inability to do so could lead to severe consequences for shareholders.
• Trading Market Risks: Continued OTCQB listing or a reversion to penny stock status could further limit liquidity and institutional investment.
• Operational Cease of R&D: Suspension of research and development may impact long-term competitiveness and revenue growth potential.

Conclusion

ParkerVision’s 2025 Annual Report highlights a company facing significant financial and operational risks, with its future heavily dependent on successful litigation outcomes, the ability to raise new capital, and the management of share dilution. Shareholders should closely monitor ongoing legal proceedings, capital raising activities, and any changes in the Company’s competitive position or market listing status, as these factors have the potential to cause significant movements in the share price.

Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Investors should perform their own due diligence and consult with financial advisors before making investment decisions. The information above is based on ParkerVision’s 2025 Annual Report and may include forward-looking statements subject to risks and uncertainties.

View PARKERVISION INC Historical chart here